Sun Pharma Advanced Research Company Appoints Anil Raghavan as Managing Director and CEO Written By Parthika Patel17 July 2026 4:44 PM ISTMumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced the appointment of its Chief Executive Officer, Anil Raghavan, as the...
SPARC Ends Licensing Deal with CMS Bridging Covering Five Drug Candidates Written By Parthika Patel27 Jun 2026 8:05 PM ISTNew Delhi: Sun Pharma Advanced Research Company Ltd. (SPARC) has announced the mutual termination of its License Agreement with CMS Bridging DMCC...
Sun Pharma Arm SPARC to Monetise PRV for USD 195 Million Written By sheeba farhat3 May 2026 6:06 PM ISTNew Delhi: Sun Pharma Advanced Research Company Ltd on Thursday said it will sell its rare paediatric disease priority review voucher for USD195...
SPARC Bags USFDA Rare Pediatric Disease Priority Review Voucher for Sezaby Written By Parthika Patel3 Feb 2026 3:00 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd (SPARC) has received a Rare Pediatric Disease Priority Review Voucher (PRV) from the United States...
Amid Debt Pressure, Sun Pharma's Research Arm SPARC Plans 40% Workforce Reduction Written By Parthika Patel9 Jan 2026 3:12 PM ISTThe latest restructuring is expected to result in annual cost savings of approximately USD 10 million.
SPARC announces retirement of Dr Chitturi Trinadha Rao - Senior Vice President, Drug Discovery Ruchika Sharma3 Nov 2023 1:30 PM ISTMumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery,...
SPARC licenses PDP-716, SDN-037 drug rights to Visiox Pharma Ruchika Sharma8 Dec 2021 1:20 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced that the company has entered into an agreement with Visiox Pharma LLC...
SPARC, Biomodifying ink antibody licensing agreement Ruchika Sharma4 Dec 2021 1:11 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently announced that the company has entered into an agreement with Biomodifying LLC...
Appointment of Anilkumar Raghavan as CEO gets SPARC shareholders nod Ruchika Sharma1 Oct 2021 4:29 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Thursday said its shareholders have approved the appointment of Anilkumar Raghavan as chief...
Sun Pharma Advanced Research Company to raise up to Rs 1800 crore Medical Dialogues Team2 Sept 2021 9:00 AM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Wednesday said it will seek shareholders' approval to raise up to Rs 1,800 crore through...
SPARC reports positive results from Phase 3 trial of ocular hypertension treatment Ruchika Sharma16 May 2021 10:00 AM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently reported positive top-line results from its Phase 3 trial (CLR_16_33) for...
SPARC issues warrants worth Rs 1,200 crore to promoter Dilip Shanghvi, others Ruchika Sharma14 May 2021 12:31 PM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) plans to raise up to Rs 1,200 crore by way of issuing warrants to the company''s promoter...
